Bnp Paribas Arbitrage, Snc »

Drugs Made In Amer Acqutn shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Drugs Made In Amer Acqutn (DMAAR) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Drugs Made In Amer Acqutn

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In Amer Acqutn held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In Amer Acqutn by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 120k 0.19

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Amazon.com Equity (AMZN)
Meta Platforms Equity (META)
Tesla Equity (TSLA)
Alphabet Equity (GOOGL)
JPMorgan Chase & Co Equity (JPM)
Broadcom Equity (AVGO)
State Street SPDR S&P Biotech ETF Fund (XBI)
Alphabet Equity (GOOG)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Cisco Systems Equity (CSCO)
Micron Technology Equity (MU)
Advanced Micro Devices Equity (AMD)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Drugs Made In Amer Acqutn

Polar Securities
Hudson Bay Capital Management
Harraden Circle Investments
Highbridge Capital Management
Toronto-Dominion Bank
Aristeia Capital
Mangrove Partners
Linden Advisors
Shaolin Capital Management
Atw Spac Management
Boothbay Fund Management
Wolverine Asset Management
Glazer Capital
Westchester Capital Management
LMR Partners

View all funds holding Drugs Made In Amer Acqutn